<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Therap Adv Gastroenterol</journal-id>
<journal-id journal-id-type="iso-abbrev">Therap Adv Gastroenterol</journal-id>
<journal-id journal-id-type="publisher-id">TAG</journal-id>
<journal-id journal-id-type="hwp">sptag</journal-id>
<journal-title-group>
<journal-title>Therapeutic Advances in Gastroenterology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1756-283X</issn>
<issn pub-type="epub">1756-2848</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27134664</article-id>
<article-id pub-id-type="pmc">4830101</article-id>
<article-id pub-id-type="doi">10.1177/1756283X16630718</article-id>
<article-id pub-id-type="publisher-id">10.1177_1756283X16630718</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>What goes around comes around: novel pharmacological targets in the gut–brain axis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>González-Arancibia</surname>
<given-names>Camila</given-names>
</name>
<aff id="aff1-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Escobar-Luna</surname>
<given-names>Jorge</given-names>
</name>
<aff id="aff2-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrera-Bugueño</surname>
<given-names>Camila</given-names>
</name>
<aff id="aff3-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Díaz-Zepeda</surname>
<given-names>Camilo</given-names>
</name>
<aff id="aff4-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>González-Toro</surname>
<given-names>María P.</given-names>
</name>
<aff id="aff5-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olavarría-Ramírez</surname>
<given-names>Loreto</given-names>
</name>
<aff id="aff6-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zanelli-Massai</surname>
<given-names>Francesca</given-names>
</name>
<aff id="aff7-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gotteland</surname>
<given-names>Martin</given-names>
</name>
<aff id="aff8-1756283X16630718">Departamento de Nutrición, Facultad de Medicina, Universidad de Chile, Santiago, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bravo</surname>
<given-names>Javier A.</given-names>
</name>
<aff id="aff9-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Julio-Pieper</surname>
<given-names>Marcela</given-names>
</name>
<xref ref-type="corresp" rid="corresp1-1756283X16630718"></xref>
<aff id="aff10-1756283X16630718">Grupo de NeuroGastroBioquímica, Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Avenida Universidad 330, Curauma, Valparaíso, Chile</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-1756283X16630718">
<email>marcela.julio@pucv.cl</email>
</corresp>
<fn fn-type="conflict">
<p><bold>Conflict of interest statement:</bold> The authors declare that there is no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2016</year>
</pub-date>
<volume>9</volume>
<issue>3</issue>
<fpage>339</fpage>
<lpage>353</lpage>
<permissions>
<copyright-statement>© The Author(s), 2016</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The gut and the brain communicate bidirectionally through anatomic and humoral pathways, establishing what is known as the gut–brain axis. Therefore, interventions affecting one system will impact on the other, giving the opportunity to investigate and develop future therapeutic strategies that target both systems. Alterations in the gut–brain axis may arise as a consequence of changes in microbiota composition (dysbiosis), modifications in intestinal barrier function, impairment of enteric nervous system, unbalanced local immune response and exaggerated responses to stress, to mention a few. In this review we analyze and discuss several novel pharmacological targets within the gut–brain axis, with potential applications to improve intestinal and mental health.</p>
</abstract>
<kwd-group>
<kwd>enteric nervous system</kwd>
<kwd>gut–brain axis</kwd>
<kwd>interleukin 22</kwd>
<kwd>intestinal microbiota</kwd>
<kwd>serotonin</kwd>
<kwd>vagus nerve</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>